Standard and Targeted Biopsy During Follow-up for Active Surveillance

[摘要] Many patients diagnosed with prostate cancer have low-risk disease that is unlikely to harm them during their lifetimes. Active surveillance (AS) has emerged as a crucial treatment option for patients with favorable-risk prostate cancer. Although its use continues to expand globally, there remains a lack of consensus on the optimal follow-up strategy.1 Many studies have evaluated predictors of progression during AS in an effort to provide insight into the appropriate timing of repeat prostate biopsy.2 Some AS programs incorporate a confirmatory biopsy because early reclassification often represents sampling error from the initial biopsy.3 A relatively new addition to AS is the use of MRI-targeted biopsy (MRI-TB).

[学科分类] 基础医学